title: Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.
abstract: Expression of the high-risk human papillomavirus (HPV) E6 and E7 oncogenes is essential for the initiation and maintenance of cervical cancer. The repression of both was previously shown to result in activation of their respective tumor suppressor targets, p53 and pRb, and subsequent senescence induction in cervical cancer cells. Consequently, viral oncogene suppression is a promising approach for the treatment of HPV-positive tumors. One well-established method of E6/E7 repression involves the reexpression of the viral E2 protein which is usually deleted in HPV-positive cancer cells. Here, we show that, surprisingly, bovine papillomavirus type 1 (BPV1) E2 but not RNA interference-mediated E6/E7 repression in HPV-positive cervical cancer cells stimulates cellular motility and invasion. Migration correlated with the dynamic formation of cellular protrusions and was dependent upon cell-to-cell contact. While E2-expressing migratory cells were senescent, migration was not a general feature of cellular senescence or cell cycle arrest and was specifically observed in HPV-positive cervical cancer cells. Interestingly, E2-expressing cells not only were themselves motile but also conferred increased motility to admixed HeLa cervical cancer cells. Together, our data suggest that repression of the viral oncogenes by E2 stimulates the motility of E6/E7-targeted cells as well as adjacent nontargeted cancer cells, thus raising the possibility that E2 expression may unfavorably increase the local invasiveness of HPV-positive tumors.
authors.affiliation: Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center and University of Cincinnati,College of Medicine, Cincinnati, OH 45229, USA.
authors.forename: Monique A
authors.initials: MA
authors.lastname: Morrison
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Morreale
authors.forename: Shailaja
authors.initials: S
authors.lastname: Akunuru
authors.forename: Matthew
authors.initials: M
authors.lastname: Kofron
authors.forename: Yi
authors.initials: Y
authors.lastname: Zheng
authors.forename: Susanne I
authors.initials: SI
authors.lastname: Wells
mesh_terms: D052688:Bovine papillomavirus 1 / Q000472:pathogenicity*; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D004268:DNA-Binding Proteins / Q000378:metabolism*; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000037:antagonists & inhibitors*; D014764:Viral Proteins / Q000378:metabolism*
chemical_list: D004268:DNA-Binding Proteins; C051550:E2 protein, Bovine papillomavirus; D009856:Oncogene Proteins, Viral; D014764:Viral Proteins